In our previous studies, we reported that AKT inhibitors perifosine or MK-2206 protected against tumor growth in vitro and in vivo as a single agent, and increased the therapeutic effects of chemotherapeutic drugs in NB (17–19). This evidence concerns the gene AKT1 and neoplasm.